MEK inhibitors abrogate migration and cancer stem cell function in pancreatic ductal adenocarcinomas von Tiwary, K., Walter, K., Trajkovic-Arsic, M., Hidalgo-Sastre, A., Dierichs, L., Liffers, S., Gu, J., Gout, J., Schulte, L., Münch, J., Seufferlein, T., Sainz, B., Siveke, J., Rodriguez Aznar, E., C.Hermann, P.

Volltext